Search Results 3911-3920 of 25574 for oral

  1. Jaw tumors and cysts - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  2. 0.0. Target. 80.5%. Oral Cavity & Pharynx. 17.4. 0.0. Pancreas. 15.0. 9.1. Brain & ONS. 8.3. 7.0. County. 65.4%. Esophagus. 6.5. 4.8. Colorectal. Liver & Bile ...

  3. Oral Cavity & Pharynx. 0.3. 1.5. Target. 74.4%. Uncategorized. 0.0. 0.0. Data Sources: Incidence and Mortality from State Cancer Profiles (for FL, AZ, WI, IA.

  4. Oral Cavity & Pharynx. County. 65.6%. Ovary. 0.0. Colorectal. Pancreas. 0.0. 0.0. Adults aged 50-75 years who reported. State. Stomach. 0.0. 0.0. Thyroid. 0.0.

  5. Oral Cavity & Pharynx. 20.6 reported Mammogram in 2 years. Bladder. 15.1. 0.0. Leukemia. 12.5. 0.0. Target. 80.5%. Pancreas. Brain & ONS. Cervix. Esophagus.

  6. Testing Low Dose Tamoxifen For Invasive Breast Cancer, The (LoTam) Trial - Mayo Clinic

    * No use of oral hormone replacement therapy within 7 days prior to registration * Age ≥ 18 years * Eastern Cooperative Oncology Group (ECOG) performance ...

  7. A Study of the Effectiveness and Safety of Mepolizumab as Adjunctive Therapy in Participants with Severe Eosinophilic Asthma - Mayo Clinic

    ... oral corticosteroids. For participants ≥18 years old ICS dose must be ≥ 880 mcg/day fluticasone propionate (exactuator) or equivalent daily. For ICS/long ...

  8. A Study to Evaluate the Effectiveness and Safety of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema in Adolescents and Adults - Mayo Clinic

    Use of any estrogen-containing medications with systemic absorption (such as oral contraceptives or hormonal replacement therapy) within 4 weeks prior to ...

  9. TMJ Archives - Mayo Clinic News Network

    temporomandibular joint pain often can be relieved with less-invasive treatment options. — Dr. Jonathan Fillmore, Oral and Maxillofacial Surgery, Mayo Clinic, ...

  10. A Study to Evaluate Biomarker/ALK Inhibitor Combinations in Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol) - Mayo Clinic

    Patients must be able to take oral medications (i.e., swallow whole tablets/capsules). All females of childbearing potential must have a blood test or urine ...